Cavrotolimod

DB18216InvestigationalSmall molecule

Cavrotolimod: Overview.

Mechanism: Pharmacologically active on Toll-like receptor 9
Curator reviewed
Also known as: DNA, D(P-THIO)(T-C-G-T-C-G-T-T-T-T-G-T-C-G-T-T-T-T-G-T-C-G-T-T), 3'-(58-((3.BETA.)-CHOLEST-5-EN-3-YLOXY)-19,39,42-TRIHYDROXY-19,39-DIOXIDO-58-OXO-3,6,9,12,15,18,20,23,26,29,32,35,38,40,44,47,50,53-OCTADECAOXA-57-AZA-19,39-DIPHOSPHAOCTAPENTACONT-1-YL HYDR
Code names: AST-008

Resolves to

Compound

Targets

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cavrotolimod, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.